Lance Armstrong, 41, is set to sit down with Oprah Winfrey, 58, on Monday for an interview in which he is expected to come clean about his use of performance-enhancing substances, which cost him his seven Tour de France titles, a lifetime ban from professional cycling, and his chairmanship and board of directors seat at The Livestrong Foundation.

The interview marks Armstrong's first public appearance since being stripped of his championships. There had been rumors that Armstrong was blood doping for years — rumors that, up until his ban, he had strongly denied. However, when offered a chance to appeal the ruling by the Union Cycliste Internationale (UCI), Armstrong refused.

Many believe this will be an opportunity by Armstrong to rehabilitate his image. Some are not interested in hearing his apologies, if he has any to offer. "Understand something about Armstrong: Whatever version of the truth he will give Oprah is nothing more than a last resort for him, even as he will certainly tell us about the lives of all the cancer patients he’s touched because of Livestrong," wrote Mike Lupica of the New York Daily News. "It will just be another example of Armstrong saying anything to save his own sorry self. This isn’t about somebody else’s life. Just his own."

The interview is scheduled to air Thursday on Oprah Winfrey's OWN Network.

Get Uinterview's FREE iPhone App For Daily News Updates here.

Get the FREE Uinterview iPad app here and watch our videos anywhere.

For more like this:

Lance Armstrong Resigns From Cancer Foundation, Gets Dropped By Nike

Lance Armstrong Stops Fighting Doping Charges, Stripped Of Seven Titles

Olympic Athletes Disqualified For Doping

Giants' Melky Cabrera Gets 50-Game Suspension For Doping

Runner Debbie Dunn Out Of Olympics Due To Doping


  • JayNorth
    JayNorth on

    Here is a preview of the interview at

  • Sara31sa
    Sara31sa on

    as Mark said have you explored … how working on emails anyone can earn about $4500 in a month. Just read this page at

Comments are closed.

Read more about: